Pralsetinib Products | Cleanchem - Pralsetinib is a tyrosine kinase inhibitor used to treat cancers with RET gene alterations, such as non-small cell lung cancer (NSCLC) and thyroid cancer. It works by blocking the abnormal RET protein, which is responsible for the growth and spread of cancer cells. Pralsetinib has shown promising results in treating RET-driven cancers and is used when other treatments have failed.

Cat. No: CL-PRS-NO-02

CAS No: NA

Mol. F: C18H24N6O4

Mol. Wt: 388.4

Inv. Status: Custom Synthesis

Cat. No: CL-PRS-NO-03

CAS No: NA

Mol. F: C17H22N6O4

Mol. Wt: 374.4

Inv. Status: Custom Synthesis

Cat. No: CL-PRS-NO-04

CAS No: NA

Mol. F: C2413C3H30FN915N2O4

Mol. Wt: 596.6

Inv. Status: Custom Synthesis